What the business is, and whether it's a good one at a fair price.
Operates a chain of pharmacy retail stores across India selling pharmaceutical and non-pharmaceutical products, with a smaller diagnostic services arm. In FY26, the retail pharmacy segment contributed 98.1% of segment revenue at Rs 6,760.1 crore, while diagnostic services added 1.9% at Rs 131 crore. The store network reached 5,476 stores covering 2.9 million sq ft as of Q1 FY27, spanning 14 states and supported by 27,686 employees. The business added 146 net stores in Q1 FY27 (131 of them under a franchisee model) and has guided to 800 net additions for FY27. In Q1 FY27, pharmacy revenue grew 21.8% year-on-year; mature stores older than 12 months delivered a 10.4% store-level EBITDA margin. Private-label products made up 20% of pharmacy revenue (10.7% pharma plus 9.3% non-pharma), with a subscription base of 44-45 lakh members paying a Rs 149 fee. Subsidiary Optival Health Solutions runs roughly 90% of operations. Employee costs are the largest cost line at 12.8% of revenue, with depreciation at 4.1% and other operating expenses at 4.6%.
Measured from the filed financials, judged against its Retailing peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from MEDPLUS HEALTH SERV LTD's filed financials and exchange disclosures
MEDPLUS HEALTH SERV LTD is a Retailing company listed on NSE and BSE, trading under the symbol MEDPLUS.
Yes. Over the trailing twelve months MEDPLUS HEALTH SERV LTD reported a net profit of ₹210 Cr on revenue of ₹7,229 Cr.
Not in the latest reported year — MEDPLUS HEALTH SERV LTD's dividend payout for FY26 was nil.
Effectively yes. It holds ₹198 Cr more cash than debt. Debt stands at 0.00× equity.
On trailing P/E, MEDPLUS HEALTH SERV LTD ranks 41 of 56 in Retailing — cheaper than 27% of them, against an industry median of 20.4×. This is a position, not a valuation judgement.
On a typical session MEDPLUS HEALTH SERV LTD moves 0.91% — that is the median absolute close-to-close move across its last 269 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by MEDPLUS HEALTH SERV LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.